Myeloid Therapeutics
- Biotech or pharma, therapeutic R&D
Myeloid Therapeutics: clinical-stage therapies that harness innate immunity (myeloid cells) to fight solid tumors, including: in vivo programming of myeloid cells w/ LNP/CARs (MT-302, 301, others); and ex vivo engineering of monocytes (MT-101, CD5)
Address
CambridgeMassachusetts
United States